Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;174(9):1336-1338.
doi: 10.7326/M21-1341. Epub 2021 May 25.

Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants

Affiliations

Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants

Olivier Marion et al. Ann Intern Med. 2021 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M21-1341.

Figures

Figure.
Figure.. Prevalence of anti–SARS-CoV-2 antibodies at 4 wk after the second vaccine dose in all transplant patients and by type of organ transplant.
Percentages with exact binomial 95% CIs are presented.

References

    1. Kates OS , Haydel BM , Florman SS , et al; UW COVID-19 SOT Study Team. COVID-19 in solid organ transplant: a multi-center cohort study. Clin Infect Dis. 2020. [PMID: ] doi:10.1093/cid/ciaa1097 - DOI - PMC - PubMed
    1. Sahin U , Muik A , Derhovanessian E , et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature. 2020;586:594-599. [PMID: ] doi:10.1038/s41586-020-2814-7 - DOI - PubMed
    1. Boyarsky BJ , Werbel WA , Avery RK , et al. Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients. JAMA. 2021. [PMID: ] doi:10.1001/jama.2021.4385 - DOI - PMC - PubMed
    1. Grupper A , Rabinowich L , Schwartz D , et al. Reduced humoral response to mRNA SARS-Cov-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus. Am J Transplant. 2021. [PMID: ] doi:10.1111/ajt.16615 - DOI - PMC - PubMed
    1. Marinaki S , Adamopoulos S , Degiannis D , et al. Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients [Letter]. Am J Transplant. 2021. [PMID: ] doi:10.1111/ajt.16607 - DOI - PMC - PubMed

LinkOut - more resources